GEACX | GRHIX | GEACX / GRHIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 8 years | - |
Gain YTD | -11.206 | 9.290 | -121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.78B | 437M | 408% |
Annual Yield % from dividends | 3.81 | 3.07 | 124% |
Returns for 1 year | -3.13 | 11.39 | -27% |
Returns for 3 years | -23.72 | 40.32 | -59% |
Returns for 5 years | N/A | 169.77 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTTX | 28.03 | 0.59 | +2.15% |
Fidelity Advisor Biotechnology M | |||
NWAPX | 40.95 | 0.33 | +0.81% |
Nationwide BNY Mellon Dyn US Eq Inc Egl | |||
RIFYX | 30.96 | 0.22 | +0.72% |
Victory RS Science and Technology Y | |||
MFQTX | 18.59 | 0.06 | +0.32% |
AMG Veritas Global Focus I | |||
WLGCX | 25.00 | -0.06 | -0.24% |
Delaware Ivy Large Cap Growth Fund C |